Literature DB >> 16902263

Molecular analysis of the CLCNKB gene in Japanese patients with classic Bartter syndrome.

Toshihiro Tajima1, Mitsuru Nawate, Yutaka Takahashi, Yumiko Mizoguchi, Shigetaka Sugihara, Masaaki Yoshimoto, Mutsumi Murakami, Masanori Adachi, Katsuhiko Tachibana, Hiroshi Mochizuki, Kenji Fujieda.   

Abstract

Deletions or mutations in the gene encoding the basolateral chloride channel CLC-Kb (CLCNKB) cause classic Bartter syndrome (MIM 602023), which is characterized by hypokalemic metabolic alkalosis, hyperreninemic hyperaldosteronism and hypercalciura. These patients are usually diagnosed during infancy or childhood due to failure to thrive and growth retardation. The purpose of this study was to investigate the underlying mutations in Japanese patients with classic Bartter syndrome. Seven Japanese patients from seven different families diagnosed as having classic Bartter syndrome were studied. Analysis of CLCNKB demonstrated a large deletion in two patients, a partial deletion in one patient and two mutations (DeltaL130 in exon 4 and W610X in exon 16) in the remaining four patients. DeltaL130 is a novel mutation, but W610X was previously reported in three unrelated Japanese patients. Six out of the seven patients were diagnosed due to typical characteristics of classic Bartter syndrome such as failure to thrive and poor weight gain however, one patient was asymptomatic with mild hypokalemia. In conclusion, we identified a novel mutation of the CLCNKB gene, DeltaL130. We did not determine whether the W610X mutation in our patients was from a common ancestor or if this mutation is frequent in Japan.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902263     DOI: 10.1507/endocrj.k06-034

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Chronic renal failure in a boy with classic Bartter's syndrome due to a novel mutation in CLCNKB coding for the chloride channel.

Authors:  Chien-Ming Lin; Jeng-Daw Tsai; Yi-Fen Lo; Ming-Tso Yan; Sung-Sen Yang; Shih-Hua Lin
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

2.  Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations.

Authors:  Amar Al Shibli; Hassib Narchi
Journal:  World J Methodol       Date:  2015-06-26

3.  Mixed Bartter-Gitelman syndrome: an inbred family with a heterogeneous phenotype expression of a novel variant in the CLCNKB gene.

Authors:  Amar Al-Shibli; Madinah Yusuf; Issam Abounajab; Patrick J Willems
Journal:  Springerplus       Date:  2014-02-18

4.  Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Álvaro Madrid; Sara Chocrón; Inmaculada Nadal; Mercedes Navarro; Elena Lucas; Julia Fijo; Mar Espino; Zilac Espitaletta; Víctor García Nieto; David Barajas de Frutos; Reyner Loza; Guillem Pintos; Luis Castaño; Gema Ariceta
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

5.  Splicing Characterization of CLCNKB Variants in Four Patients With Type III Bartter Syndrome.

Authors:  Chunli Wang; Yuan Han; Jiaran Zhou; Bixia Zheng; Wei Zhou; Huaying Bao; Zhanjun Jia; Aihua Zhang; Songming Huang; Guixia Ding; Fei Zhao
Journal:  Front Genet       Date:  2020-02-21       Impact factor: 4.599

6.  Historical and geographical distribution of the founder mutation c.610G>A; p.Ala204Thr in the CLCNKB gene linked to Bartter syndrome type III in Spain.

Authors:  Ramón Peces; Rocío Mena; Carlos Peces; Pilar Barruz; Hernando Trujillo; Agustín Carreño; Laura Espinosa; Rafael Selgas; Pablo Lapunzina; Julián Nevado
Journal:  Clin Kidney J       Date:  2021-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.